An	O
evaluation	B:C0220825
of	O
neuroendocrine	O
dysfunction	O
following	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
:	O
A	O
prospective	O
study	I:C0033522
.	O

An	O
evaluation	O
of	O
neuroendocrine	B:C0027912
dysfunction	O
following	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
:	O
A	O
prospective	O
study	I:C0033522
.	O

An	O
evaluation	O
of	O
neuroendocrine	O
dysfunction	O
following	O
acute	O
aneurysmal	B:C0751530
subarachnoid	I:C0751530
hemorrhage	I:C0751530
:	O
A	O
prospective	O
study	I:C0033522
.	O

An	O
evaluation	O
of	O
neuroendocrine	O
dysfunction	O
following	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
:	O
A	O
prospective	B:C0033522
study	I:C0033522
.	O

The	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
pattern	B:C0449774
of	O
neuroendocrine	O
changes	O
in	O
cases	O
of	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
(	O
subarachnoid	O
hemorrhage	I:C0751530
)	O
.	O

The	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
pattern	O
of	O
neuroendocrine	B:C0027912
changes	O
in	O
cases	O
of	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
(	O
subarachnoid	O
hemorrhage	I:C0751530
)	O
.	O

The	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
pattern	O
of	O
neuroendocrine	O
changes	O
in	O
cases	O
of	O
acute	O
aneurysmal	B:C0751530
subarachnoid	I:C0751530
hemorrhage	I:C0751530
(	O
subarachnoid	O
hemorrhage	I:C0751530
)	O
.	O

The	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
pattern	O
of	O
neuroendocrine	O
changes	O
in	O
cases	O
of	O
acute	O
aneurysmal	O
subarachnoid	I:C0751530
hemorrhage	I:C0751530
(	O
subarachnoid	B:C0751530
hemorrhage	I:C0751530
)	O
.	O

Endocrine	B:C0014136
assessment	O
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	O
aneurysmal	O
SAH	I:C0751530
presenting	O
within	O
7	O
days	O
of	O
ictus	O
.	O

Endocrine	O
assessment	B:C0220825
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	O
aneurysmal	O
SAH	I:C0751530
presenting	O
within	O
7	O
days	O
of	O
ictus	O
.	O

Endocrine	O
assessment	O
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	O
aneurysmal	B:C0751530
SAH	I:C0751530
presenting	O
within	O
7	O
days	O
of	O
ictus	O
.	O

Endocrine	O
assessment	O
was	O
performed	O
in	O
100	O
consecutive	O
cases	O
of	O
acute	O
aneurysmal	O
SAH	I:C0751530
presenting	O
within	O
7	O
days	O
of	O
ictus	B:C0038454
.	O

The	O
gonadotropic	B:C0018061
,	O
somatotrophic	O
,	O
thyrotropic	O
,	O
and	O
corticotrophic	O
axes	O
were	O
evaluated	O
for	O
their	O
possible	O
dysfunction	O
.	O

The	O
gonadotropic	O
,	O
somatotrophic	B:C0037663
,	O
thyrotropic	O
,	O
and	O
corticotrophic	O
axes	O
were	O
evaluated	O
for	O
their	O
possible	O
dysfunction	O
.	O

The	O
gonadotropic	O
,	O
somatotrophic	O
,	O
thyrotropic	B:C0040160
,	O
and	O
corticotrophic	O
axes	O
were	O
evaluated	O
for	O
their	O
possible	O
dysfunction	O
.	O

The	O
gonadotropic	O
,	O
somatotrophic	O
,	O
thyrotropic	O
,	O
and	O
corticotrophic	B:C0001655
axes	O
were	O
evaluated	O
for	O
their	O
possible	O
dysfunction	O
.	O

The	O
gonadotropic	O
,	O
somatotrophic	O
,	O
thyrotropic	O
,	O
and	O
corticotrophic	O
axes	O
were	O
evaluated	B:C0220825
for	O
their	O
possible	O
dysfunction	O
.	O

A	O
total	O
of	O
100	O
cases	O
(	O
38	O
males	O
,	O
62	O
females	O
;	O
age	O
range	O
-	O
17	O
-	O
76	O
years	O
;	O
mean	O
age	O
-	O
43.6	O
years	O
)	O
of	O
acute	O
subarachnoid	B:C0751530
hemorrhage	I:C0751530
were	O
studied	O
.	O

A	O
total	O
of	O
100	O
cases	O
(	O
38	O
males	O
,	O
62	O
females	O
;	O
age	O
range	O
-	O
17	O
-	O
76	O
years	O
;	O
mean	O
age	O
-	O
43.6	O
years	O
)	O
of	O
acute	O
subarachnoid	O
hemorrhage	I:C0751530
were	O
studied	B:C0008972
.	O

The	O
aneurysms	B:C0002940
were	O
located	O
in	O
the	O
anterior	O
circulation	I:C0007818
(	O
n	O
=	O
95	O
)	O
and	O
posterior	O
circulation	I:C0007818
(	O
n	O
=	O
5	O
)	O
.	O

The	O
aneurysms	O
were	O
located	O
in	O
the	O
anterior	B:C0007818
circulation	I:C0007818
(	O
n	O
=	O
95	O
)	O
and	O
posterior	O
circulation	I:C0007818
(	O
n	O
=	O
5	O
)	O
.	O

The	O
aneurysms	O
were	O
located	O
in	O
the	O
anterior	O
circulation	I:C0007818
(	O
n	O
=	O
95	O
)	O
and	O
posterior	B:C0007818
circulation	I:C0007818
(	O
n	O
=	O
5	O
)	O
.	O

The	O
most	O
common	O
hormone	O
deficiency	O
was	O
of	O
growth	B:C0037663
hormone	I:C0037663
(	O
n	O
=	O
67	O
)	O
,	O
followed	O
by	O
gonadotrophin	O
(	O
n	O
=	O
50	O
)	O
,	O
corticotrophin	O
(	O
n	O
=	O
49	O
)	O
and	O
thyrotrophin	O
(	O
n	O
=	O
35	O
)	O
.	O

The	O
most	O
common	O
hormone	O
deficiency	O
was	O
of	O
growth	O
hormone	I:C0037663
(	O
n	O
=	O
67	O
)	O
,	O
followed	O
by	O
gonadotrophin	B:C0018061
(	O
n	O
=	O
50	O
)	O
,	O
corticotrophin	O
(	O
n	O
=	O
49	O
)	O
and	O
thyrotrophin	O
(	O
n	O
=	O
35	O
)	O
.	O

The	O
most	O
common	O
hormone	O
deficiency	O
was	O
of	O
growth	O
hormone	I:C0037663
(	O
n	O
=	O
67	O
)	O
,	O
followed	O
by	O
gonadotrophin	O
(	O
n	O
=	O
50	O
)	O
,	O
corticotrophin	B:C0001655
(	O
n	O
=	O
49	O
)	O
and	O
thyrotrophin	O
(	O
n	O
=	O
35	O
)	O
.	O

The	O
most	O
common	O
hormone	O
deficiency	O
was	O
of	O
growth	O
hormone	I:C0037663
(	O
n	O
=	O
67	O
)	O
,	O
followed	O
by	O
gonadotrophin	O
(	O
n	O
=	O
50	O
)	O
,	O
corticotrophin	O
(	O
n	O
=	O
49	O
)	O
and	O
thyrotrophin	B:C0040160
(	O
n	O
=	O
35	O
)	O
.	O

Hyperprolactinemia	B:C0020514
was	O
noted	O
in	O
10	O
cases	O
.	O

One	B:C0857439
-	I:C0857439
pituitary	I:C0857439
hormone	I:C0857439
axis	I:C0857439
deficiency	I:C0857439
was	O
noted	O
in	O
26	O
cases	O
while	O
67	O
cases	O
had	O
two	O
or	O
more	O
pituitary	O
hormone	I:C0032015
axes	O
dysfunction	O
.	O

One	O
-	I:C0857439
pituitary	I:C0857439
hormone	I:C0857439
axis	I:C0857439
deficiency	I:C0857439
was	O
noted	O
in	O
26	O
cases	O
while	O
67	O
cases	O
had	O
two	O
or	O
more	O
pituitary	B:C0032015
hormone	I:C0032015
axes	O
dysfunction	O
.	O

A	O
total	O
of	O
93	O
cases	O
had	O
hormonal	B:C0019932
dysfunction	O
in	O
one	O
or	O
more	O
pituitary	O
hormone	I:C0032015
axes	I:C0032015
,	O
and	O
seven	O
cases	O
had	O
no	O
hormonal	O
dysfunction	O
.	O

A	O
total	O
of	O
93	O
cases	O
had	O
hormonal	O
dysfunction	O
in	O
one	O
or	O
more	O
pituitary	B:C0032015
hormone	I:C0032015
axes	I:C0032015
,	O
and	O
seven	O
cases	O
had	O
no	O
hormonal	O
dysfunction	O
.	O

A	O
total	O
of	O
93	O
cases	O
had	O
hormonal	O
dysfunction	O
in	O
one	O
or	O
more	O
pituitary	O
hormone	I:C0032015
axes	I:C0032015
,	O
and	O
seven	O
cases	O
had	O
no	O
hormonal	B:C0019932
dysfunction	O
.	O

Endocrine	O
dysfunction	O
occurs	O
in	O
93	O
%	O
cases	O
of	O
acute	O
subarachnoid	B:C0751530
hemorrhage	I:C0751530
and	O
multiple	O
pituitary	O
hormone	I:C0032015
axes	I:C0032015
dysfunction	O
occurs	O
in	O
67	O
%	O
cases	O
.	O

Endocrine	O
dysfunction	O
occurs	O
in	O
93	O
%	O
cases	O
of	O
acute	O
subarachnoid	O
hemorrhage	I:C0751530
and	O
multiple	O
pituitary	B:C0032015
hormone	I:C0032015
axes	I:C0032015
dysfunction	O
occurs	O
in	O
67	O
%	O
cases	O
.	O

It	O
is	O
suggested	O
that	O
hormonal	B:C0019932
evaluation	O
should	O
be	O
considered	O
as	O
part	O
of	O
management	O
of	O
acute	O
subarachnoid	O
hemorrhage	I:C0751530
.	O

It	O
is	O
suggested	O
that	O
hormonal	O
evaluation	B:C0220825
should	O
be	O
considered	O
as	O
part	O
of	O
management	O
of	O
acute	O
subarachnoid	O
hemorrhage	I:C0751530
.	O

It	O
is	O
suggested	O
that	O
hormonal	O
evaluation	O
should	O
be	O
considered	O
as	O
part	O
of	O
management	O
of	O
acute	O
subarachnoid	B:C0751530
hemorrhage	I:C0751530
.	O

